A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jae Hui | - |
dc.contributor.author | Sagong, Min | - |
dc.contributor.author | Woo, Se Joon | - |
dc.contributor.author | Kim, Yu Cheol | - |
dc.contributor.author | Cho, Heeyoon | - |
dc.contributor.author | Lee, Young Hoon | - |
dc.contributor.author | Byon, Iksoo | - |
dc.contributor.author | Jo, Young Joon | - |
dc.contributor.author | Chin, Hee Seung | - |
dc.contributor.author | Lee, Youkyung | - |
dc.contributor.author | Chae, Jae Eun | - |
dc.contributor.author | Kang, Se Woong | - |
dc.date.accessioned | 2022-10-25T07:42:39Z | - |
dc.date.available | 2022-10-25T07:42:39Z | - |
dc.date.created | 2022-10-06 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/172579 | - |
dc.description.abstract | To evaluate the real-world treatment outcomes in patients with neovascular age-related macular degeneration (nAMD) in Korea, focusing on retinal fluid resolution. This multi-institutional retrospective chart review study, analyzed medical records of patients with nAMD (age >= 50 years) who received their first anti-vascular endothelial growth factor (VEGF) treatment in ophthalmology clinics across South Korea between January 2017 and March 2019. The primary endpoint was the proportion of patients with retinal fluid after 12 months of anti-VEGF treatment. The association between fluid-free period and VA gains was also evaluated. A total of 600 patients were enrolled. At baseline, 97.16% of patients had retinal fluid; after 12 months of anti-VEGF treatment, 58.10% of patients had persistent retinal fluid. VA improvements were relatively better in patients with absence of retinal fluid compared with presence of retinal fluid (+ 12.29 letters vs. + 6.45 letters at month 12; P < .0001). Longer duration of absence of retinal fluid over first 12 months correlated with better VA gains at month 12 (P < .01). More than half of the study patients with nAMD had retinal fluid even after 12 months of treatment with their current anti-VEGF. Presence of retinal fluid was associated with relatively worse VA outcomes. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATURE PORTFOLIO | - |
dc.title | A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Heeyoon | - |
dc.identifier.doi | 10.1038/s41598-022-18158-z | - |
dc.identifier.scopusid | 2-s2.0-85136984802 | - |
dc.identifier.wosid | 000842561700030 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.12, no.1, pp.1 - 13 | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 13 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | OPTICAL COHERENCE TOMOGRAPHY | - |
dc.subject.keywordPlus | GROWTH-FACTOR THERAPY | - |
dc.subject.keywordPlus | INTRAVITREAL RANIBIZUMAB | - |
dc.subject.keywordPlus | AFLIBERCEPT | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | AMD | - |
dc.identifier.url | https://www.nature.com/articles/s41598-022-18158-z | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.